Breaking News Instant updates and real-time market news.

PFE

Pfizer

$37.55

0.025 (0.07%)

14:35
07/13/18
07/13
14:35
07/13/18
14:35

Pfizer reports FDA approves sNDA to broaden XTANDI indication

Astellas Pharma and Pfizer announced the U.S. Food and Drug Administration approved a supplemental New Drug Application, or sNDA, for XTANDI following FDA Priority Review designation, based on results from the Phase 3 PROSPER trial. The FDA action broadens the indication for XTANDI to men with castration-resistant prostate cancer, now including men with non-metastatic CRPC. "This approval makes XTANDI the first and only oral medication FDA-approved for both non-metastatic and metastatic CRPC. XTANDI was first approved by the FDA in 2012 for the treatment of patients with metastatic CRPC who had previously received docetaxel, and was granted approval in 2014 for chemotherapy-naive men with metastatic CRPC," the companies stated.

  • 22

    Aug

  • 10

    Sep

PFE Pfizer
$37.55

0.025 (0.07%)

06/28/18
WELS
06/28/18
NO CHANGE
WELS
Wells says Amazon deal, Walgreens results have negative read for drug pricing
After Amazon (AMZN) agreed to acquire online pharmacy PillPack, reportedly for $1B, Wells Fargo analyst David Maris noted that he has long stated that Amazon would enter the pharmacy business and warned about the risk to drug pricing in such a scenario. Maris also noted that Walgreens (WBA) reported its U.S. retail pharmacy comparable store sales fell 1.2% in Q3, adding that retailers tend to push drugmakers on price when they feel pressure and the read-through from its report may be negative for drug pricing. Publicly traded large-cap drugmakers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
07/11/18
ARGS
07/11/18
NO CHANGE
ARGS
Hold
Pfizer valuation is appropriate, says Argus
Argus analyst David Toung kept his Hold rating on Pfizer, saying the company's valuation at 12.2-times his expected FY19 earnings - below the 12.4-times peer group average for pharmaceutical stocks - is appropriate after its revenue growth slowed in Q1. The analyst notes that higher sales from Eliquis, Ibrance, and Xejanz are being offset by declining sales of drugs faced with a loss of market exclusivity, adding that he remains concerned about competition for Pfizer's key products.
07/11/18
NEED
07/11/18
UPGRADE
Target $5
NEED
Buy
Scynexis upgraded to Buy at Needham after positive phase 2b data for SCY-078
As reported earlier, Needham analyst Alan Carr upgraded Scynexis (SCYX) to Buy from Hold with a price target of $5 after the company's positive Phase 2b trial results of oral SCY-078 in Vulvovaginal Candidiasis. The analyst notes that the data shows the 1-day 300mg BID SCY-078 is "at least equivalent and likely more effective" than the standard 150mg single dose of fluconazole made by Pfizer (PFE). Carr adds that the gastrointestinal tolerability of SCY-078 is also acceptable, which was a key concern in the earlier Phase 2a trial. The analyst further states that the new valuation accounts for expected commercialization of the drug in VVC amid a likely strong interest in a new oral agent suggested by his ObGyn survey last month.
07/11/18
WELS
07/11/18
NO CHANGE
WELS
Drug stocks may not react favorably to Pfizer price rollback, Trump tweets, says Wells Fargo
Wells Fargo analyst David Maris notes that there was widespread media coverage of drug price increases taken recently by several large cap drug companies, with President Trump criticizing Pfizer (PFE) for taking these price increases. On Tuesday, Pfizer confirmed it was rolling back its July drug price increases following a conversation with President Trump, he adds. Maris believes that drug stocks will not react favorably to this news, given the chilling effect this will likely have on others looking to take price increases. Nonetheless, the analyst points out that the price increases taken in July are only a small number of increases taken over the past year or several years, so the impact of the rollback to the healthcare system is insignificant in the big picture. Other publicly traded companies in the space include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Roche (RHHBY) and Sanofi (SNY).

TODAY'S FREE FLY STORIES

NTAP

NetApp

$78.07

-0.99 (-1.25%)

14:55
10/18/18
10/18
14:55
10/18/18
14:55
Options
NetApp put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

14:50
10/18/18
10/18
14:50
10/18/18
14:50
General news
Canada retail sales preview »

Canada retail sales…

14:50
10/18/18
10/18
14:50
10/18/18
14:50
General news
Canada CPI preview »

Canada CPI preview:…

BKD

Brookdale Senior Living

$8.68

-0.07 (-0.80%)

14:49
10/18/18
10/18
14:49
10/18/18
14:49
Hot Stocks
Brookdale Senior Living moves off lows, said to cancel out of conference »

An afternoon move off the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 11

    Dec

PYPL

PayPal

$77.79

-2.32 (-2.90%)

14:49
10/18/18
10/18
14:49
10/18/18
14:49
Options
PayPal options imply 9.5% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 22

    Oct

  • 13

    Nov

  • 13

    Nov

  • 26

    Nov

GOOG

Alphabet

$1,087.23

-28.76 (-2.58%)

, GOOGL

Alphabet Class A

$1,096.20

-30.47 (-2.70%)

14:47
10/18/18
10/18
14:47
10/18/18
14:47
Hot Stocks
Google opens Hardware Stores in NYC and Chicago »

Google opens pop-up…

GOOG

Alphabet

$1,087.23

-28.76 (-2.58%)

GOOGL

Alphabet Class A

$1,096.20

-30.47 (-2.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 07

    Nov

  • 03

    Mar

TTWO

Take-Two

$126.11

-5.89 (-4.46%)

, GME

GameStop

$15.11

-0.23 (-1.50%)

14:47
10/18/18
10/18
14:47
10/18/18
14:47
Periodicals
Smaller game stores may not get 'Red Dead 2' until November, Kotaku says »

Smaller video game…

TTWO

Take-Two

$126.11

-5.89 (-4.46%)

GME

GameStop

$15.11

-0.23 (-1.50%)

BBY

Best Buy

$72.46

-1.37 (-1.86%)

SNE

Sony

$55.85

-2.06 (-3.56%)

MSFT

Microsoft

$108.47

-2.25 (-2.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 21

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 28

    Nov

  • 03

    Mar

MDR

McDermott

$14.61

-0.57 (-3.75%)

14:45
10/18/18
10/18
14:45
10/18/18
14:45
Options
McDermott call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBGI

Sinclair Broadcast

$29.58

-0.06 (-0.20%)

14:43
10/18/18
10/18
14:43
10/18/18
14:43
Periodicals
Sinclair Broadcast confirms 'Stirr' streaming service to launch soon, Axios says »

At the NAB Show in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 13

    Nov

SBPH

Spring Bank Pharmaceuticals

$14.43

0.05 (0.35%)

14:35
10/18/18
10/18
14:35
10/18/18
14:35
Hot Stocks
Breaking Hot Stocks news story on Spring Bank Pharmaceuticals »

Adage Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 27

    Nov

LKQ

LKQ Corp.

$28.19

-0.43 (-1.50%)

14:30
10/18/18
10/18
14:30
10/18/18
14:30
Options
Repeat call buyers in Call buyers in LKQ Corp as shares fall to 52-week lows »

Repeat call buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 01

    Nov

  • 06

    Nov

  • 13

    Dec

AG

First Majestic

$6.26

0.02 (0.32%)

14:25
10/18/18
10/18
14:25
10/18/18
14:25
Options
First Majestic call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
10/18/18
10/18
14:17
10/18/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
10/18/18
10/18
14:16
10/18/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$115.93

-1.16 (-0.99%)

14:14
10/18/18
10/18
14:14
10/18/18
14:14
Hot Stocks
Disney plans to build nature-inspired mixed-use resort on Bay Lake »

A new nature-inspired,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

VLKAY

Volkswagen

$0.00

(0.00%)

, POAHY

Porsche

$0.00

(0.00%)

14:13
10/18/18
10/18
14:13
10/18/18
14:13
Periodicals
Porsche exec expects to repeat record car sales in 2018, Reuters says »

Oliver Blume, CEO of…

VLKAY

Volkswagen

$0.00

(0.00%)

POAHY

Porsche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BT

BT Group

$15.91

-0.05 (-0.31%)

, WP

Worldpay

$94.21

-2.455 (-2.54%)

14:10
10/18/18
10/18
14:10
10/18/18
14:10
Periodicals
BT offers CEO position to Worldpay's Jansen, Bloomberg says »

BT Group (BT) has offered…

BT

BT Group

$15.91

-0.05 (-0.31%)

WP

Worldpay

$94.21

-2.455 (-2.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 26

    Nov

SNAP

Snap

$6.76

-0.3 (-4.25%)

14:10
10/18/18
10/18
14:10
10/18/18
14:10
Options
Time spreads in Snap as shares see further weakness »

Time spreads in Snap as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 07

    Nov

AXP

American Express

$102.51

-1.88 (-1.80%)

, PYPL

PayPal

$77.80

-2.31 (-2.88%)

14:02
10/18/18
10/18
14:02
10/18/18
14:02
Hot Stocks
American Express, PayPal announce expanded strategic partnership »

American Express (AXP)…

AXP

American Express

$102.51

-1.88 (-1.80%)

PYPL

PayPal

$77.80

-2.31 (-2.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 18

    Oct

  • 22

    Oct

  • 05

    Nov

  • 13

    Nov

  • 13

    Nov

  • 26

    Nov

GSVC

GSV Capital

$6.75

0.13 (1.96%)

14:00
10/18/18
10/18
14:00
10/18/18
14:00
Options
Far downside put buyers in GSV Capital Corporation »

Far downside put buyers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCHW

Charles Schwab

$46.56

-1.49 (-3.10%)

13:55
10/18/18
10/18
13:55
10/18/18
13:55
Options
Charles Schwab put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

FSNUY

Fresenius SE

$0.00

(0.00%)

, AKRX

Akorn

$6.94

-0.18 (-2.53%)

13:51
10/18/18
10/18
13:51
10/18/18
13:51
Hot Stocks
Akorn appeals ruling in Fresenius buyout case to Delaware Supreme Court »

Akorn (AKRX) announced…

FSNUY

Fresenius SE

$0.00

(0.00%)

AKRX

Akorn

$6.94

-0.18 (-2.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GT

Goodyear Tire

$20.47

-0.98 (-4.57%)

, CTB

Cooper Tire

$24.67

-0.97 (-3.78%)

13:50
10/18/18
10/18
13:50
10/18/18
13:50
OnTheFly
Goodyear, Cooper Tire slide after Michelin cuts full year market forecasts »

Shares of Goodyear Tire…

GT

Goodyear Tire

$20.47

-0.98 (-4.57%)

CTB

Cooper Tire

$24.67

-0.97 (-3.78%)

MGDDY

Michelin

$0.00

(0.00%)

CTTAY

Continental AG

$0.00

(0.00%)

CNHI

CNH Industrial

$10.61

-0.44 (-3.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 29

    Oct

  • 29

    Oct

ZION

Zions Bancorp

$47.57

-0.86 (-1.78%)

13:45
10/18/18
10/18
13:45
10/18/18
13:45
Options
Zions Bancorp call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

ARQL

ArQule

$4.52

-0.03 (-0.66%)

13:43
10/18/18
10/18
13:43
10/18/18
13:43
Hot Stocks
ArQule rises 9% in afternoon trading amid conference appearance »

ArQule, which is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.